Skip to content
TrialScanner

NCT02944383

A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia

Phase 2CompletedMTVALead

Registry record

Lead sponsor
NeuroBo Pharmaceuticals Inc.
Conditions
Severe Hypertriglyceridemia; Mixed Dyslipidaemia
Primary completion
Jan 11, 2018Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02944383 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02944383: A 12-Week Study to Assess... | TrialScanner